Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate

dc.creatorPerrotti, M
dc.creatorBahamondes, L
dc.creatorPetta, C
dc.creatorCastro, S
dc.date2001
dc.dateSEP
dc.date2014-11-19T20:18:53Z
dc.date2015-11-26T18:05:38Z
dc.date2014-11-19T20:18:53Z
dc.date2015-11-26T18:05:38Z
dc.date.accessioned2018-03-29T00:47:56Z
dc.date.available2018-03-29T00:47:56Z
dc.identifierFertility And Sterility. Elsevier Science Inc, v. 76, n. 3, n. 469, n. 473, 2001.
dc.identifier0015-0282
dc.identifierWOS:000170863300007
dc.identifier10.1016/S0015-0282(01)01936-7
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/67026
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/67026
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/67026
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1293184
dc.descriptionObjective: To compare the bone mineral density of users of combined oral contraceptives (OC) or depot medroxyprogesterone acetate (depot-MPA) with women who have never used a hormonal contraceptive method. Design: Cross-sectional study. Setting: Academic tertiary-care hospital. Patient(s): A total of 189 women, aged 30 to 34 years old, were allocated to three groups: 63 who had used OC for at least 2 years; 63 who had used depot-MPA for at least 2 years; and 63 control women who had never used hormonal contraceptives. Intervention(s): Each woman's bone mineral density (BMD) was evaluated at the distal and ultradistal section of the radius of the nondominant forearm by the use of single x-ray absorptiometry. Main Outcome Measure(s): We obtained BMD measurements for each participant. Result(s): Independent of the period of use and the section of the forearm studied, we found no difference in BMD for OC or depot-MPA users when compared to women who had never used hormonal contraceptive methods. In addition, BMD was similar between OC users and depot-MPA users. The multiple linear regression analysis showed that the variables associated with BMD were weight, number of pregnancies, and the woman's occupation. Conclusion(s): Women aged 30 to 34 years who have used OC or depot-NIPA have similar BMD as control women. These findings suggest that the use of OC or depot-MPA does not affect the BMD of women in this age group. (Fertil Steril(R) 2001;76:469-73. (C) 2001 by American Society for Reproductive Medicine.).
dc.description76
dc.description3
dc.description469
dc.description473
dc.languageen
dc.publisherElsevier Science Inc
dc.publisherNew York
dc.publisherEUA
dc.relationFertility And Sterility
dc.relationFertil. Steril.
dc.rightsfechado
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.sourceWeb of Science
dc.subjecthormonal contraceptives
dc.subjectbone density
dc.subjectdepot medroxyprogesterone acetate
dc.subjectMineral Density
dc.subjectPostmenopausal Women
dc.subjectHormone
dc.titleForearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución